Find a Clinical Trial
Filter
Dompe' Reparixin study
COVID-19
All genders
18+
Recruiting now
Department of Medicine, Division of Geographic Medicine + Infectious Diseases
Collagen Urine Assay
Male
50-80
Recruiting now
Department of Urology
AN2 EBO301 MAC Study
Mycobacterial disease
All genders
18+
Recruiting now
Department of Medicine, Division of Geographic Medicine + Infectious Diseases
Moderna mRNA 1273 study
COVID-19
All genders
0-12
Recruiting now
Department of Medicine, Division of Geographic Medicine + Infectious Diseases
Takeda footprint
Neonatal care
All genders
0-1
Recruiting now
Department of Obstetrics + Gynecology
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin (VOLGA)
Bladder cancer
All genders
18+
Recruiting now
Department of Medicine, Cancer Center
Letermovir for secondary prophylaxis for CMV disease in solid organ transplant recipients
Cytomegalovirus infection
All genders
18-75
Recruiting now
Department of Medicine, Division of Geographic Medicine + Infectious Diseases
LYS228 Pharmacokinetics for Complicated UTI
Urinary tract infections
All genders
18-85
Recruiting now
Department of Urology
TAP Block and minimally invasive hysterectomy for pain control
Uterine cancer
Female
18-80
Recruiting now
Department of Obstetrics + Gynecology
The Connection study
Premature babies, Premature birth
All genders
No minimum age
Recruiting now
Department of Obstetrics + Gynecology